Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
FinoGene Oy
OY
In liquidation
Y-tunnus 3434856-6
Emponkaari 11, 21620
Kuusisto
Diagnostic imaging services and medical laboratory activities
·
NACE 8691
Est. 2024 · 2 years old
— employees
Share
Finland
/
Companies
/
Diagnostic imaging services and medical laboratory activities
/
FinoGene Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2024
Income statement
EUR thousands
Item
2024
Revenue
0
Staff expenses
−0
EBITDA
0
Depreciation & amort.
−0
EBIT
0
Net financials
0
Profit before tax
0
Tax
−0
Net profit
0
Balance sheet
EUR thousands
Item
2024
Total assets
34
Equity
−1
Long-term debt
0
Short-term debt
35
Total debt
35
Financial ratios
5-year trend
EBITDA-margin
0.0%
This company
15.8%
Market median
-100% vs market
2024
2024
Soliditetsgrad
-3.4%
This company
38.2%
Market median
-109% vs market
2024
2024
Egenkapitalforrentning
0.0%
This company
18.4%
Market median
-100% vs market
2024
2024
Nettoresultatgrad
0.0%
This company
8.1%
Market median
-100% vs market
2024
2024
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2024
2024
Gæld/egenkapital
30.46×
This company
0.62×
Market median
-4813% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-03-27 – 2024-12-31
View
PDF
More on FinoGene Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
